BMEA - Company ID 0001840439
Biomea Fusion, Inc. trades as BMEA. This page tracks Biomea Fusion, Inc. through 276 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Next research step
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Quarterly report | 10-Q | 2026-05-11 |
| Major company event | 8-K | 2026-05-11 |
| Major company event | 8-K | 2026-04-28 |
| Proxy statement | DEF 14A | 2026-04-27 |
| Annual report to shareholders | ARS | 2026-04-27 |
| Insider trade | 4 | 2026-04-03 |
| Insider trade | 4 | 2026-04-03 |
| Annual report | 10-K | 2026-03-24 |
The largest companies sharing Biomea Fusion, Inc.'s SEC industry classification (pharmaceutical preparations).
In its latest fiscal year Biomea Fusion, Inc. reported a net loss of $61.80M.